Qianjiang Yongan Pharmaceutical Co., Ltd.

SZSE:002365.SZ

9.87 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income -12.313132.72119.045118.659106.909178.903132.95561.98917.18331.72223.00775.35669.76846.10765.053102.58468.94937.462
Depreciation & Amortization 135.182123.624115.959113.066112.76479.869.87671.38469.78155.6540.37918.93616.44813.40110.6667.8146.50
Deferred Income Tax 6.8242.416-3.789-5.359-4.96631.629-1.4560.2110.188000000000
Stock Based Compensation 00.9412.3511.476011.28737.39700000000000
Change In Working Capital 93.599.119-152.409-26.37215.39968.394-21.149-35.606-11.539-66.2667.687-14.9110.11-13.954-40.48249.172-15.6640
Accounts Receivables 18.85163.248-172.134-66.8679.55314.121-85.919-9.155-13.767-10.7788.362-27.02000000
Inventory 87.734-10.004-63.65519.343-7.492-16.857-19.27-8.319-9.136-17.772-6.093-1.8331.33-10.0410.1494.5835.2370
Accounts Payables -13.085-56.54287.16926.51118.30439.585.495-18.34211.177000000000
Other Working Capital -6.262.416-3.789-5.359-4.96685.25-1.879-27.287-2.403-48.49313.78-13.0768.78-3.914-40.63144.59-20.9010
Other Non Cash Items 197.92828.46110.6535.1924.474-13.07415.636-13.233-4.818-1.843-7.425-8.632-5.096-1.491.193-1.1031.294-37.462
Operating Cash Flow 244.257387.28101.811206.662239.545314.023197.31884.53470.60719.26363.64870.7591.2344.06436.429158.46861.0790
Investing Activities:
Investments In Property Plant And Equipment -120.741-149.073-63.048-104.409-134.391-269.497-289.471-40.13-34.119-50.687-99.926-120.181-248.026-104.517-45.976-72.189-60.772-17.679
Acquisitions Net 0.9530.384-35.937105.079135.395-00.04740.1334.393-0.676100.2980248.02600000
Purchases Of Investments -1,484.2-1,110.689-823.197-1,215.735-607.004-698.763-56.798-52.214-14-69-300-100-1500000
Sales Maturities Of Investments 1,392.7261,028.982943.51988.394692.949551.51791.53230.64912.55310.3958.65678.5496.6061.487000.3990.103
Other Investing Activites 45.21300.499-104.409-134.3918.1956.147-40.13-34.1192.805-99.9261.823-248.026-9.524-45.976-72.18911.260.125
Investing Cash Flow -166.049-230.39521.827-331.081-47.442-408.547-248.544-61.696-35.293-107.163-120.897-39.809-341.419-262.554-45.976-72.189-49.112-17.451
Financing Activities:
Debt Repayment -30-40-132.347-21-70-9.823-10.05900000000-30-6
Common Stock Issued 00057.67370.8570127.83200000000000
Common Stock Repurchased 000-4.934-70.8570000000000000
Dividends Paid -29.468-1.565-29.428-43.08-29.468-19.653-18.828-5.61-11.22-5.61-39.377-37.373-30.505-42.345-35-2.86-12.735-0.177
Other Financing Activities -6.30459.37923.845136.163-62.0873.68139.832-1.9414.50000692.2050051.9790
Financing Cash Flow -65.77217.813-139.246122.431-99.145-15.973111.181-7.551-6.72-5.61-39.377-37.373-30.505649.86-35-2.869.243-6.177
Other Information:
Effect Of Forex Changes On Cash 7.0786.511-1.082-5.1521.4151.099-4.6052.3270.1780.006-0.069-0.004-0.112-0.0470000
Net Change In Cash 51.456181.209-16.691-7.13994.373-109.39755.3517.61328.771-93.503-96.694-6.435-280.806431.322-44.54783.41921.2117.486
Cash At End Of Period 326.172274.71593.506110.196117.33522.962132.3677.0159.39730.625124.129220.823227.259508.06576.743121.2937.87116.66